Gongwin Biopharm Holdings Statistics

Total Valuation

TPEX:6617 has a market cap or net worth of TWD 9.66 billion. The enterprise value is 8.13 billion.

Market Cap	9.66B
Enterprise Value	8.13B

Important Dates

The last earnings date was Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6617 has 122.62 million shares outstanding. The number of shares has increased by 6.00% in one year.

Current Share Class	122.62M
Shares Outstanding	122.62M
Shares Change (YoY)	+6.00%
Shares Change (QoQ)	-0.76%
Owned by Insiders (%)	24.80%
Owned by Institutions (%)	0.06%
Float	54.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	257.92
PB Ratio	3.85
P/TBV Ratio	3.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-91.95
EV / Sales	216.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-72.72

Financial Position

The company has a current ratio of 10.92, with a Debt / Equity ratio of 0.05.

Current Ratio	10.92
Quick Ratio	9.82
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-1.02
Interest Coverage	-40.53

Financial Efficiency

Return on equity (ROE) is -3.40% and return on invested capital (ROIC) is -4.08%.

Return on Equity (ROE)	-3.40%
Return on Assets (ROA)	-3.89%
Return on Invested Capital (ROIC)	-4.08%
Return on Capital Employed (ROCE)	-7.45%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.01
Inventory Turnover	3.49

Taxes

In the past 12 months, TPEX:6617 has paid 196,000 in taxes.

Income Tax	196,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.88% in the last 52 weeks. The beta is -0.01, so TPEX:6617's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	-30.88%
50-Day Moving Average	91.04
200-Day Moving Average	97.89
Relative Strength Index (RSI)	36.58
Average Volume (20 Days)	146,457

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6617 had revenue of TWD 37.46 million and -88.37 million in losses. Loss per share was -0.71.

Revenue	37.46M
Gross Profit	18.97M
Operating Income	-193.78M
Pretax Income	-96.61M
Net Income	-88.37M
EBITDA	-184.82M
EBIT	-193.78M
Loss Per Share	-0.71

Full Income Statement

Balance Sheet

The company has 1.64 billion in cash and 114.08 million in debt, giving a net cash position of 1.53 billion or 12.45 per share.

Cash & Cash Equivalents	1.64B
Total Debt	114.08M
Net Cash	1.53B
Net Cash Per Share	12.45
Equity (Book Value)	2.51B
Book Value Per Share	20.54
Working Capital	1.68B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -104.42 million and capital expenditures -7.33 million, giving a free cash flow of -111.75 million.

Operating Cash Flow	-104.42M
Capital Expenditures	-7.33M
Free Cash Flow	-111.75M
FCF Per Share	-0.91

Full Cash Flow Statement

Margins

Gross margin is 50.63%, with operating and profit margins of -517.26% and -235.90%.

Gross Margin	50.63%
Operating Margin	-517.26%
Pretax Margin	-257.89%
Profit Margin	-235.90%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6617 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.00%
Shareholder Yield	-6.00%
Earnings Yield	-0.91%
FCF Yield	-1.16%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6617 has an Altman Z-Score of 29.72.

Altman Z-Score	29.72
Piotroski F-Score	n/a